Screening-detected refractive errors in infants born after assisted reproductive technology: a prospective cohort study - Takeaways - MDSpire

Screening-detected refractive errors in infants born after assisted reproductive technology: a prospective cohort study

  • By

  • Xin Zou

  • Mamoud Alieu Jalloh

  • Zijin Wang

  • Yan Zong

  • Yangqian Jiang

  • Tao Jiang

  • Lei You

  • Rui Qin

  • Hong Lv

  • Yuxin Liu

  • Tianyu Sun

  • Bo Xu

  • Xiumei Han,

  • Xiaoyu Liu

  • Kun Zhou

  • Guangfu Jin

  • Hongxia Ma

  • Yuan Lin

  • Zhibin Hu

  • Hu Liu

  • Jiangbo Du

  • Jiong Li

  • March 30, 2026

  • 0 min

Share

  • 1

    The study evaluated refractive errors in infants conceived via assisted reproductive technology (ART) at one year of age.

  • 2

    Findings suggest that ART conception may not increase the risk of screening-detected refractive errors compared to spontaneous conception.

  • 3

    The research included 2739 ART-conceived infants and 3574 spontaneously conceived infants, following standardized vision screening protocols.

  • 4

    Differences in infertility diagnoses and ART procedures were analyzed to assess their potential impact on visual development.

  • 5

    The study highlights the need for cautious interpretation of protocol-related differences within the ART population.

Original Source(s)

Screening-detected refractive errors in infants born after assisted reproductive technology: a prospective cohort study

  • by Xin Zou, Mamoud Alieu Jalloh, Zijin Wang, Yan Zong, Yangqian Jiang, Tao Jiang, Lei You, Rui Qin, Hong Lv, Yuxin Liu, Tianyu Sun, Bo Xu, Xiumei Han,, Xiaoyu Liu, Kun Zhou, Guangfu Jin, Hongxia Ma, Yuan Lin, Zhibin Hu, Hu Liu, Jiangbo Du, Jiong Li

  • March 30, 2026

Related Content

Age-related changes in lens thickness in children aged 3-17 years and its association with myopia and ocular biological parameters: a cross-sectional and longitudinal study

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Validation of a Regression Model for Predicting Refractive Outcomes Post-Cataract Surgery in Pterygium-Affected Eyes